Effect of hydroxychloroquine on prevention of covid-19 virus
Not Applicable
Recruiting
- Conditions
- Covid-19 prophylaxis.
- Registration Number
- IRCT20120826010664N6
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 310
Inclusion Criteria
Treatment staff who are in contact with patients
who have at least 3 shift a week in the hospital
consent to participate in the study.
Exclusion Criteria
History of covid-19 virus infection
clinical symptoms such as fever, nausea, dispenea and myalgia in the past two months
history of underlying diseases
hypersensitivity to hydroxychloroquine
G6PD enzyme deficiency
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Covid-19 infection. Timepoint: One, two and three months after starting the drug. Method of measurement: Covid-19 PCR test and clinical symptoms.
- Secondary Outcome Measures
Name Time Method